180 related articles for article (PubMed ID: 25646865)
1. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system.
Oh J; An JW; Oh SI; Oh KW; Kim JA; Lee JS; Kim SH
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):202-8. PubMed ID: 25646865
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses.
Gladman M; Dharamshi C; Zinman L
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):426-32. PubMed ID: 25025935
[TBL] [Abstract][Full Text] [Related]
3. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain.
López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P; Alfonso-Sanchez JL
Amyotroph Lateral Scler; 2009 Aug; 10(4):237-43. PubMed ID: 18821088
[TBL] [Abstract][Full Text] [Related]
4. The costs of amyotrophic lateral sclerosis, according to type of care.
van der Steen I; van den Berg JP; Buskens E; Lindeman E; van den Berg LH
Amyotroph Lateral Scler; 2009 Feb; 10(1):27-34. PubMed ID: 18608087
[TBL] [Abstract][Full Text] [Related]
5. Health and social care costs of managing amyotrophic lateral sclerosis (ALS): an Irish perspective.
Connolly S; Heslin C; Mays I; Corr B; Normand C; Hardiman O
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):58-62. PubMed ID: 25285902
[TBL] [Abstract][Full Text] [Related]
6. Financial cost of amyotrophic lateral sclerosis: a case study.
Obermann M; Lyon M
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):54-7. PubMed ID: 25245119
[TBL] [Abstract][Full Text] [Related]
7. Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.
Schönfelder E; Osmanovic A; Müschen LH; Petri S; Schreiber-Katz O
Orphanet J Rare Dis; 2020 Jun; 15(1):149. PubMed ID: 32532288
[TBL] [Abstract][Full Text] [Related]
8. Patients' self-perceived burden, caregivers' burden and quality of life for amyotrophic lateral sclerosis patients: a cross-sectional study.
Geng D; Ou R; Miao X; Zhao L; Wei Q; Chen X; Liang Y; Shang H; Yang R
J Clin Nurs; 2017 Oct; 26(19-20):3188-3199. PubMed ID: 27874996
[TBL] [Abstract][Full Text] [Related]
9. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study.
Jennum P; Ibsen R; Pedersen SW; Kjellberg J
J Neurol; 2013 Mar; 260(3):785-93. PubMed ID: 23104122
[TBL] [Abstract][Full Text] [Related]
10. The economic impact of amyotrophic lateral sclerosis: a systematic review.
Gladman M; Zinman L
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):439-50. PubMed ID: 25924979
[TBL] [Abstract][Full Text] [Related]
11. Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis.
Pagnini F; Rossi G; Lunetta C; Banfi P; Castelnuovo G; Corbo M; Molinari E
Psychol Health Med; 2010 Dec; 15(6):685-93. PubMed ID: 21154021
[TBL] [Abstract][Full Text] [Related]
12. Investigating the economic burden of ALS in Greece: a cost-of-illness approach.
Athanasakis K; Kyriopoulos II; Sideris M; Rentzos M; Evdokimidis J; Kyriopoulos J
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):63-4. PubMed ID: 25019279
[TBL] [Abstract][Full Text] [Related]
13. Life factors affecting depression and burden in amyotrophic lateral sclerosis caregivers.
Qutub K; Lacomis D; Albert SM; Feingold E
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):292-7. PubMed ID: 24555470
[TBL] [Abstract][Full Text] [Related]
14. Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregivers.
Trail M; Nelson N; Van JN; Appel SH; Lai EC
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Mar; 5(1):40-5. PubMed ID: 15204023
[TBL] [Abstract][Full Text] [Related]
15. Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea.
Oh H; Sin MK; Schepp KG; Choi-Kwon S
Rehabil Nurs; 2012; 37(3):136-44. PubMed ID: 22549631
[TBL] [Abstract][Full Text] [Related]
16. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
Zhu TY; Tam LS; Li EK
Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy.
Schepelmann K; Winter Y; Spottke AE; Claus D; Grothe C; Schröder R; Heuss D; Vielhaber S; Mylius V; Kiefer R; Schrank B; Oertel WH; Dodel R
J Neurol; 2010 Jan; 257(1):15-23. PubMed ID: 19629566
[TBL] [Abstract][Full Text] [Related]
18. A cost comparison of hospice care in amyotrophic lateral sclerosis and lung cancer.
Elman LB; Stanley L; Gibbons P; McCluskey L
Am J Hosp Palliat Care; 2006; 23(3):212-6. PubMed ID: 17060281
[TBL] [Abstract][Full Text] [Related]
19. Ventilator use, respiratory problems, and caregiver well-being in korean patients with amyotrophic lateral sclerosis receiving home-based care.
Kim CH; Kim MS
J Neurosci Nurs; 2014 Oct; 46(5):E25-32. PubMed ID: 25188688
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.
Chiò A; Hammond ER; Mora G; Bonito V; Filippini G
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):38-44. PubMed ID: 24336810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
